Tandem Diabetes Care Inc (TNDM)
30.81
+0.07
(+0.23%)
USD |
NASDAQ |
Nov 22, 16:00
30.90
+0.09
(+0.29%)
After-Hours: 20:00
Tandem Diabetes Care Cash from Operations (Quarterly): 26.78M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 26.78M |
| June 30, 2024 | -5.275M |
| March 31, 2024 | -7.996M |
| December 31, 2023 | -7.216M |
| September 30, 2023 | 0.055M |
| June 30, 2023 | -6.323M |
| March 31, 2023 | -18.33M |
| December 31, 2022 | 5.82M |
| September 30, 2022 | 23.94M |
| June 30, 2022 | 6.901M |
| March 31, 2022 | 13.80M |
| December 31, 2021 | 19.64M |
| September 30, 2021 | 34.14M |
| June 30, 2021 | 28.90M |
| March 31, 2021 | 28.68M |
| December 31, 2020 | 15.24M |
| September 30, 2020 | 14.56M |
| June 30, 2020 | 15.50M |
| March 31, 2020 | -20.63M |
| December 31, 2019 | 19.44M |
| September 30, 2019 | 23.02M |
| June 30, 2019 | 3.568M |
| March 31, 2019 | -4.124M |
| December 31, 2018 | 14.13M |
| Date | Value |
|---|---|
| September 30, 2018 | -3.457M |
| June 30, 2018 | -6.723M |
| March 31, 2018 | -12.27M |
| December 31, 2017 | -11.64M |
| September 30, 2017 | -19.02M |
| June 30, 2017 | -14.66M |
| March 31, 2017 | -20.81M |
| December 31, 2016 | -13.58M |
| September 30, 2016 | -18.15M |
| June 30, 2016 | -13.49M |
| March 31, 2016 | -15.94M |
| December 31, 2015 | -10.25M |
| September 30, 2015 | -14.34M |
| June 30, 2015 | -18.76M |
| March 31, 2015 | -15.42M |
| December 31, 2014 | -13.54M |
| September 30, 2014 | -13.58M |
| June 30, 2014 | -17.30M |
| March 31, 2014 | -16.96M |
| December 31, 2013 | -12.83M |
| September 30, 2013 | -10.96M |
| June 30, 2013 | -15.17M |
| March 31, 2013 | -8.811M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-20.63M
Minimum
Mar 2020
34.14M
Maximum
Sep 2021
9.382M
Average
14.18M
Median
Cash from Operations (Quarterly) Benchmarks
| Boston Scientific Corp | 1.002B |
| Masimo Corp | 25.60M |
| RxSight Inc | 0.65M |
| Perspective Therapeutics Inc | 3.366M |
| Xtant Medical Holdings Inc | -1.718M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -19.90M |
| Cash from Financing (Quarterly) | -4.519M |
| Free Cash Flow | -37.35M |
| Free Cash Flow Per Share (Quarterly) | 0.3287 |
| Free Cash Flow to Equity (Quarterly) | 21.04M |
| Free Cash Flow to Firm (Quarterly) | 21.54M |
| Free Cash Flow Yield | -1.86% |